Hyperkalemia: Causes and Levels

Definition and Normal Range

Severity Levels

Causes

1. Pseudohyperkalemia (Artifactual)

• Hemolysis of the blood sample (most common) - mechanical trauma during venipuncture
• Excessive fist clenching during blood draw
• Leukocytosis (WBC > 70,000 × 10⁹/L) - K+ leaks from WBCs in vitro
• Thrombocytosis (platelets > 1,000,000 × 10⁹/L) - K+ released from platelets during clotting
• Erythrocytosis
• Hereditary pseudohyperkalemia - rare genetic increase in passive erythrocyte K+ permeability (e.g., SLC4A1 mutations)
• Cooling of blood after venipuncture (reduces cellular uptake)

2. Transcellular Shift (K+ moves out of cells into ECF)

• Harrison's Principles 22E (2025), Washington Manual, Morgan & Mikhail

3. Decreased Renal Excretion (Most Common True Cause)

A. Reduced GFR / Renal Failure

• Chronic kidney disease (CKD) - hyperkalemia typically does not occur until GFR < 30 mL/min
• Acute kidney injury (AKI) with oliguria/anuria - oligo/anuria is a major cause
• Volume depletion (dehydration, hemorrhage, CHF, cirrhosis) - reduced distal tubular flow

B. Aldosterone Deficiency (Hypoaldosteronism)

• Addison disease (primary adrenal insufficiency) - autoimmune, infectious (TB, HIV, CMV, fungal), infiltrative (amyloidosis, malignancy), hereditary, hemorrhagic
• Hyporeninemic hypoaldosteronism (Type 4 RTA) - common in diabetic nephropathy and elderly patients; low renin → low aldosterone despite intact adrenal glands
• Congenital enzyme defects: 21-hydroxylase deficiency, aldosterone synthase deficiency

C. Aldosterone Resistance (Pseudohypoaldosteronism)

• Type 1 PHA - hereditary end-organ resistance to aldosterone (salt-wasting, low BP)
• Type 2 PHA (Gordon syndrome) - familial hyperkalemic hypertension (salt-retaining, high BP)

D. Drugs that Impair Renal K+ Excretion (Major Cause)

• Washington Manual of Medical Therapeutics, Morgan & Mikhail, Brenner & Rector's The Kidney

4. Increased Potassium Intake

• Dietary excess: salt substitutes (KCl), dried fruits, nuts, bananas, potatoes, spinach, tomatoes
• Potassium supplements
• Massive blood transfusions (stored blood has elevated K+)
• Penicillin G (contains K+)

ECG Changes with Levels

Key Clinical Points

• Critically ill patients often develop hyperkalemia from multiple simultaneous factors (e.g., AKI + ACE inhibitor + volume depletion + metabolic acidosis)
• In CKD patients, even drugs with minimal K+ effects in healthy people (beta-blockers, ACE inhibitors) can cause dangerous hyperkalemia
• Succinylcholine is contraindicated in burns, severe muscle trauma, and denervation injuries due to exaggerated K+ release
• The rate of rise is often more important than the absolute value - acute hyperkalemia at 6.5 mEq/L may be more dangerous than chronic hyperkalemia at 6.8 mEq/L

Transcellular Shift of Potassium - Explained Clearly

The Foundation: Why Shifts Matter So Much

• Intracellular (ICF): ~140 mEq/L × 28 L = 3,920 mEq stored inside cells
• Extracellular (ECF): ~4.2 mEq/L × 14 L = only 59 mEq in blood/plasma

The Gatekeeper: Na+/K+-ATPase Pump

• Pumps 3 Na+ OUT of the cell
• Pumps 2 K+ IN to the cell
• Runs continuously using ATP energy
• Maintains the steep K+ gradient (140 mEq/L inside vs. 4 mEq/L outside)

Mechanisms of Transcellular Shift (K+ OUT of cells → Hyperkalemia)

1. Acidosis

Important exception: Lactic acidosis and ketoacidosis (anion gap acidoses) do NOT cause significant K+ shift because the organic acid anions (lactate, beta-hydroxybutyrate) can cross cell membranes along with H+, so the K+ exchange is not needed for electroneutrality. - Harrison's Principles 22E (2025)

2. Insulin Deficiency

3. Beta-blockade (Non-selective Beta-blockers)

• Beta-2 stimulation → K+ enters cells → serum K+ falls
• Beta-blockade (propranolol, nadolol, carvedilol) → pump activity drops → K+ shifts OUT → hyperkalemia

4. Hyperosmolality (High Osmolarity States)

5. Cell Lysis (Release of Intracellular K+)

6. Succinylcholine

• Normal, healthy patients: rise of ~0.5 mEq/L (safe)
• Burns, denervation, crush injury, prolonged immobility: rise of 4-8+ mEq/L (potentially fatal) because these conditions up-regulate acetylcholine receptors ("extra-junctional receptors") massively, multiplying the K+ release
• Succinylcholine is contraindicated in these situations

7. Digoxin Toxicity

8. Aldosterone Deficiency

9. Strenuous Exercise

• Beta-blockade (blunted re-uptake)
• Insulin deficiency
• High-intensity or prolonged exercise

Summary Table

Why Hyperkalemia Causes ECG Changes - The Complete Mechanism

Step 1: Understand the Normal Cardiac Action Potential

• P wave = atrial depolarization (Phase 0 of atrial cells)
• QRS complex = ventricular depolarization (Phase 0 of ventricular cells)
• T wave = ventricular repolarization (Phase 3)

Step 2: What High K+ Does to the Resting Membrane Potential

Normal: Inside cell = 140 mEq/L K+, Outside = 4 mEq/L → RMP = -90 mV

Step 3: How Each ECG Change is Produced

Early Hyperkalemia (K+ 5.5-6.5 mEq/L): Peaked T Waves + Short QT

• Faster Phase 3 → repolarization is quicker and more complete
• On the ECG: T wave becomes taller, narrower, and "peaked" (symmetric, narrow base)
• QT interval shortens (repolarization finishes faster)

Moderate Hyperkalemia (K+ 6.5-7.5 mEq/L): P Wave Flattening + PR Prolongation

1. Partially inactivates voltage-gated Na+ channels (these channels require the cell to be fully repolarized to -90 mV before they can reopen - if the cell never returns to -90 mV, fewer Na+ channels are available)
2. Atrial conduction slows → P wave widens and flattens
3. AV node conduction slows → PR interval prolongs

Severe Hyperkalemia (K+ 7.0-8.0 mEq/L): QRS Widening

• Phase 0 (the rapid Na+ upstroke) becomes slower and weaker
• Conduction through ventricular muscle slows
• The QRS widens and takes on the appearance of a bundle branch block
• R wave amplitude decreases, S wave deepens
• ST segment may elevate or depress (can mimic STEMI or Brugada pattern)

Critical Hyperkalemia (K+ > 8-10 mEq/L): Sine Wave → Death

1. Ventricular fibrillation
2. Pulseless electrical activity
3. Asystole

The Full ECG Progression - Summary

Fig: Severe hyperkalemia - wide QRS merging into T wave, absent P waves

Fig: Progression of hyperkalemia ECG changes

Why the ECG is Used Clinically (Not Just the Blood Test)

1. Speed - ECG result is immediate. A serum K+ lab takes 30-60 minutes. In a crashing patient, you cannot wait.
2. Clinical correlation - The same K+ level (e.g., 6.5) may be dangerous in one patient (acute rise) and tolerated in another (chronic CKD). The ECG shows whether the heart is actually being affected.
3. Treatment urgency - ECG changes determine the order and choice of interventions:
   • ECG changes present → give calcium gluconate first (membrane stabilizer - works in 1-3 min)
   • No ECG changes → can proceed with K+ removal at a less urgent pace

One-Sentence Summary of the Mechanism

In Which Conditions Is Hyperkalemia Most Dangerous?

1. End-Stage Renal Disease (ESRD) / Dialysis Patients

• The kidney is the primary route for K+ excretion. In ESRD, it is completely gone.
• Between dialysis sessions (especially over weekends - 2-3 day gaps), potassium accumulates continuously with no safety valve.
• ESRD patients also carry concurrent LV hypertrophy, heart failure, and valvular disease - a heart already structurally compromised is far more vulnerable to arrhythmias from K+ changes.
• Both hyperkalemia before dialysis AND the rapid K+ drop during dialysis create dangerous swings. Post-dialysis hypokalemia can persist 6-8 hours and trigger sudden cardiac death.
• Uremia, acidosis, and calcium-phosphorus imbalance (all present in ESRD) independently worsen arrhythmia risk on top of hyperkalemia.

"Uremia, hyperkalemia, acidosis, and disorders of calcium-phosphorous balance all link to higher rates of atrial and ventricular arrhythmias." - Braunwald's Heart Disease

2. Acute Kidney Injury (AKI) with Oliguria or Anuria

• Unlike CKD, which develops slowly allowing some adaptation, AKI causes K+ to rise acutely over hours to days.
• The cardiac cells have had no time to adapt to the rising K+, so even a K+ of 6.5 mEq/L can cause fatal arrhythmias in AKI, whereas CKD patients might tolerate 6.8 chronically.
• Rhabdomyolysis and tumor lysis syndrome combine AKI (impaired excretion) with massive K+ release (cell lysis) - a double hit that drives K+ to dangerously high levels very rapidly.
• Rate of rise matters as much as absolute level.

3. Chronic Kidney Disease (CKD) Stage 3-5

• Most common risk factor for hyperkalemia overall.
• GFR < 30 mL/min marks the threshold where the kidneys can no longer excrete enough K+.
• CKD patients are typically on ACE inhibitors/ARBs (which raise K+), and have concurrent diabetes, heart failure, and metabolic acidosis - all stacking the risk.
• A study found patients with hyperkalemia in CKD had a 4.4-fold higher risk of all-cause mortality and 5.1-fold higher risk of heart failure compared to normokalemic CKD patients.

4. Heart Failure

• The failing heart already has abnormal myocyte electrophysiology, reduced reserve, and susceptibility to arrhythmias at lower K+ thresholds than a normal heart.
• Heart failure patients often have:
  • Reduced renal perfusion → impaired K+ excretion
  • Diabetes as comorbidity
  • They are prescribed spironolactone/eplerenone + ACE inhibitors + ARBs together - a combination that dramatically raises K+
• The RALES trial (spironolactone in heart failure) was associated with a spike in hyperkalemia-related deaths in real-world practice after publication, because physicians combined multiple RAAS-blocking drugs without adequate K+ monitoring.

5. Diabetic Nephropathy / Hyporeninemic Hypoaldosteronism (Type 4 RTA)

• Diabetes creates a "perfect storm": insulin deficiency (impairs K+ entry into cells) + hyporeninemic hypoaldosteronism (impairs renal K+ excretion) + nephropathy (reduces GFR).
• These three mechanisms hit simultaneously, making even modest dietary K+ intake dangerous.
• Type 4 RTA is the most common cause of hyperkalemia in outpatients with mild-to-moderate CKD.
• Patients are often on ACE inhibitors for renoprotection - adding another K+-raising mechanism.

6. Metabolic Acidosis (especially non-anion gap)

• Acidosis causes transcellular K+ shift OUT of cells (~0.6 mEq/L rise per 0.1 pH unit drop).
• It also directly reduces Na+/K+-ATPase activity.
• When acidosis occurs on top of CKD or AKI, it can rapidly push K+ from a mild level (5.5) into severe territory (7+) within hours.
• Addison disease (adrenal insufficiency) combines acidosis + aldosterone deficiency + often dehydration - hyperkalemia here is a medical emergency.

7. Digitalis Toxicity

• Digoxin inhibits Na+/K+-ATPase → raises serum K+.
• But the simultaneous Na+/K+-ATPase blockade directly impairs myocardial conduction independently, meaning the heart is doubly sensitized.
• Hyperkalemia + digoxin toxicity creates additive cardiotoxicity - the ECG changes and arrhythmia risk occur at lower K+ levels than in other conditions.
• Calcium gluconate (the first-line membrane stabilizer for hyperkalemia) is relatively contraindicated in digoxin toxicity because hypercalcemia worsens digoxin toxicity ("stone heart").

8. Burns, Crush Injury, and Major Trauma

• Massive cell lysis releases enormous quantities of intracellular K+ within hours.
• These patients are simultaneously hypovolemic (reduced renal blood flow → impaired excretion) and acidotic.
• Succinylcholine, commonly used for intubation in trauma, can cause a further catastrophic K+ rise (4-8+ mEq/L) in burn and crush patients due to upregulation of extrajunctional acetylcholine receptors - enough to cause cardiac arrest on induction.

9. Tumor Lysis Syndrome (TLS)

• Occurs when chemotherapy kills a large tumor burden rapidly - cancer cells lyse and flood the bloodstream with K+, phosphate, and uric acid.
• The simultaneous uric acid and phosphate load causes AKI, which eliminates the renal escape route.
• K+ can rise to lethal levels within 12-24 hours of chemotherapy.
• Common tumors: Burkitt lymphoma, ALL, bulky solid tumors.

Summary Table

Key Clinical Rule

• A K+ of 6.5 mEq/L in an acute MI patient with myocardial ischemia → extremely dangerous (ischemic myocardium is hypersensitive to K+)
• A K+ of 6.8 mEq/L in a stable CKD patient who has been at that level for weeks → lower immediate risk (some adaptation), but still needs treatment